Veeda Clinical Research has refiled its draft red herring prospectus for an IPO with SEBI. Founded in 2004, the company ...

Veeda Clinical Research has refiled its IPO papers with SEBI, planning to raise funds through a fresh issue and ...

Clinical research organisation Veeda Clinical Research has re-filed preliminary papers with markets regulator Sebi seeking ...

CX Partners backed Veeda Clinical Research, a full-service contract research organization (CRO) has refiled its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and ...

Clinical research organisation Veeda Clinical Research has re-filed preliminary papers with markets regulator SEBI seeking its approval to raise funds through an initial share sale. The Gujarat-based ...

Veeda Clinical Research has once again approached the markets regulator, Sebi, filing preliminary documents to initiate an initial public offering (IPO). This Gujarat-based company is seeking to raise ...

You need to be a subscriber to view this content.

The company plans an IPO to further growth. Veeda Clinical Research Refiles IPO Papers with Sebi February 3, 2025 16:00 Veeda Clinical Research has re-filed draft IPO papers with Sebi to raise funds ...